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Changes in cell cycle protein expression during experimental Inesangial
proliferative glomerulonephritis. A characteristic response to mesangial
cell injury is proliferation, which is closely linked to mesangial matrix
accumulation and the progression of glomerular disease. Cell proliferation
in non-renal cells in vitro is regulated at the level of the cell-cycle by
specific cyclins and their catalytic partners, cyclin dependent kinases
(CDK). Cyclin kinase inhibitors (CKI) prevent proliferation by inhibiting
cell-cycle progression. However, the expression of cell-cycle regulatory
proteins in the kidney and in renal disease is unknown. To determine this
we studied the expression of cell-cycle proteins in vivo in normal rats and
rats with experimental mesangial proliferative glomerulonephritis (Thyl
model). Normal quiescent rat glomeruli have a differential expression for
CKI's, where p27'°" is highly expressed, and the levels for p21 (Cipi,
Wafi, Sdil, Cap2O) (p21) are low. The onset of mesangial cell prolifera-
tion in Thyl glomerulonephritis is associated with a reduction in p27
levels when mesangial cell proliferation is maximal. Mesangial cell prolif-
eration in vivo is also associated with an increase in glomerular expression
of cyclin A, and an increase in expression and activity for CDK2. The
resolution of mesangial cell proliferation was associated with a return to
baseline levels for p27°I", while the expression for p21 increased substan-
tially. Furthermore, mesangial cell p21 expression was maintained follow-
ing the resolution of proliferation. These results provide evidence for a
complex interplay of cell-cycle regulatory proteins during the glomerular
response to injury in vivo. The marked increase in CDK2 expression
during mesangial cell proliferation and the sustained increase in p21
expression following the resolution of mesangial cell proliferation suggests
that the in vivo expression of certain cell-cycle proteins may differ from
that described in non-renal cells in vitro.
The mesangial cell (MC) is an active participant in many
progressive glomerular diseases such as IgA nephropathy, mem-
branoproliferative nephritis, lupus nephritis and diabetes [1]. A
characteristic response of the MC to injury in human disease is
cell proliferation, which may be associated with extracellular
matrix accumulation [reviewed in 2]. This phenomenon also
occurs in experimental models of glomerular injury where MC
injury occurs. In the remnant kidney model [31 and the Thyl
model of mesangial proliferative glomerulonephritis, MC prolif-
eration has been closely linked to the progression of glomerular
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disease [4], and maneuvers that reduce MC proliferation in these
experimental models, such as low protein diet [5], heparin infu-
sion [61 or complement depletion [7] also reduce subsequent
matrix expansion or sclerosis. These studies suggest that the
mechanisms responsible for the MC proliferative response to
injury in vivo may also be important in the development of
glomerulosclerosis.
In the past few years major advances have been made in the
understanding of how cell proliferation is regulated in vitro at the
level of the cell-cycle [8]. Cyclins and cyclin-dependent kinases
(CDK) constitute the major positive cell-cycle regulatory proteins
[reviewed in 9, 10]. Cyclins are periodically expressed during
specific phases of the cell-cycle, where the levels are regulated
transcriptionally and post-translationally [11]. As cells enter the
cell-cycle from quiescence (GO), D-type cyclins are synthesized
during the Gi interval. Cyclin E is maximal in late Gi, and is
essential for GI to S phase transition [12]. Cyclin A is expressed
during the S phase of the cell cycle [13]. Cyclins bind to and
activate specific cyclin dependent kinases (CDK). D-cyclins bind
to CDK4, whereas cyclins E and A bind to CDK2 [101. yclin
dependent kinases are responsible for phosphorylating and func-
tionally inactivating the retinoblastoma protein, an event that is
associated with entry into S phase [14].
The cell-cycle is also regulated at various "check points" by
negative regulatory cell-cycle proteins known as the cyclin kinase
inhibitors (CKI) [reviewed in 15]. There are two families of CKI.
The first includes the INK4 family [16, 17], while the second
family includes p21 (CipI, Wafi, Sdil, Cap2O) (p21) [18], p271<°'
and the more recently recognized member, p57IP2 [15]. CKI
arrest the cell-cycle by inhibiting specific cyclin-CDK complexes.
All CKI inhibit cyclin D-CDK4 complexes, while only p21 and
p27KP1 inhibit cyclin-CDK2 complexes [15].
The mitogenic and antiproliferative growth factors that regulate
MC proliferation both in vitro and in vivo are well known
[reviewed in 19, 20]. In glomerular disease, multiple growth
factors and cytokines are activated and the injured mesangial
cells' proliferative response reflects a balance of mitogenic and
antiproliferative growth factors and cytokines [21. Preisig and
Franch have shown a role for specific cell-cycle proteins in renal
epithelial cells in culture [21]. However, the expression of cell-
cycle regulatory proteins in the glomerulus is not known, and
while the expression of cell-cycle proteins has been extensively
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studied in various non-renal cell types in vitro, the expression of
these nuclear proteins in inflammatory states in vivo remains to be
elucidated. Furthermore, observations that have been made in
vitro do not always occur in vivo. Accordingly, the first aim of the
current study was to determine the expression of cell-cycle
regulatory proteins in the normal glomerulus in vivo, while a
second aim was to determine the expression and activity of
specific cell-cycle regulatory proteins during mesangial cell pro-
liferation in vivo in glomerular disease. Our results show that
mesangial cell proliferation in vivo in the Thyl model of experi-
mental mesangial proliferative glomerulonephritis [22] is associ-
ated with an increase in expression and activity for cyclin A-
CDK2, and a decrease in p27 expression. Resolution of mesangial
cell proliferation in vivo was associated with a normalization of
p27 levels and an increase in p21 expression.
Methods
Animal model
The Thyl model of experimental mesangial proliferative gb-
merulonephritis was induced in 180 to 220 gram male Wistar rats
(Simonsen Laboratories, Gilroy, CA, USA) by an intravenous
injection of goat anti-thymocyte plasma (0.35 ml/100 g body wt)
[22—241. Rats were sacrificed on days 1, 2, 3, 4, 5, 7 and 10 (N =
6 at each time point), where renal biopsies were taken from each
animal for immunostaining, and glomeruli were isolated by dif-
ferential sieving [25] for protein extraction. Age- and weight-
matched Wistar rats from the same colony served as normal
controls (N = 6).
Imtnunohistochemistiy
Multiple renal biopsies were taken from each rat and fixed in
different ways. Biopsies were fixed in formalin or methyl Carnoy's
solution, embedded in paraffin, and cut into 4 jm thick sections
[6, 7]. For staining on frozen sections, tissue was embedded in
O.C.T. Compound (Miles, Elkart, IN, USA) and rapidly snap
frozen in isopentane in liquid nitrogen. Sections of 4 rm thick
cryostat were fixed at room temperature for 10 minutes in either
acetone, methanol, acetone-alcohol or alcohol-ether. Pepsin di-
gestion was used to unmask antigens in acetone fixed sections as
previously described [26]. We performed indirect immunoperox-
idase double-immunostaining on frozen and paraffin embedded
sections to determine the nuclear expression of cell-cycle proteins,
and colocalize the cell-type expressing the antigen [27].
The following primary antibodies were incubated overnight at
4°C: rabbit polyclonal antibodies to cyclin A (1:5000 dilution;
provided by JMR), cyclin Di (1:100 dilution; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), cyclin E (dilution 1:200; Santa
Cruz Biotechnology), cyclin-dcpendent kinase 2 (1:4000 dilution;
Santa Cruz Biotechnology), 27Kt1 (1:1000 dilution; provided by
JMR) and p21 (1:5000; Santa Cruz Biotechnology). A murine
monoclonal 1gM antibody against proliferating ccli nuclear anti-
gen (PCNA) (1:1000 dilution; 19A2; Coulter Immunology, Hi-
aleah, FL, USA) was also incubated overnight at 4°C. Controls for
this step of the double-immunostaining included omitting the
primary antibody, substituting thc primary antibody with an
irrelevant antibody of the same Ig class, and peptide absorption
studies for the polyclonal antibodies (peptides were obtained from
same source as the primary antibody). The secondary antibody
used for the polyclonal antibodies was a biotinylated goat anti-
rabbit antibody (1:400 dilution; Vector Laboratories, Inc., Burlin-
game, CA, USA), and a peroxidase-conjugated rat anti-mouse
1gM (Zymed Laboratories, Inc., San Franscisco, CA, USA) was
used for the monoclonal antibody. Incubation was for 30 minutes
at room temperature, followed by a horseradish peroxidase
conjugated avidin D (1:2000 dilution; Vector Laboratories, Inc.)
for 20 minutes at room temperature. Black nuclear staining was
detected using diaminobenzidine (Sigma Chemical Co., St. Louis,
MO, USA) with nickel as a chromagen.
Double-immunostaining was then performed using a second
primary antibody to determine which cell type expressed each
nuclear antigen. The following primary antibodies were incubated
at room temperature for 60 minutes: OX-7, a marker of mesangial
cells (1:4000 dilution; Serotec), ED-i a marked of macrophages,
monocytes and dendritic cells (1:200; Bioproducts for Science,
Inc., Indianapolis, IN, USA), and RECA-1 a marker of endothe-
hal cells (gift of A.M. Duijvestijn, Maastricht, Netherlands) [28].
A secondary peroxidase conjugated anti-mouse IgG antibody
(1:100 dilution; Zymed Laboratories) was applied for 60 minutes
at room temperature. The brown cytoplasmic stain was deter-
mined by diaminobenzidine without nickel. The controls used for
the second step of the double-immunostaining included omitting
the second primary antibody or replacing it with an irrelevant
antibody of the same Ig class.
Semiquantitation of immunostaining
The glomerular expression for PCNA and each cyclin (cyclins
Dl, E, A), cyclin-dependent kinase (CDK2) and cyclin kinase
inhibitors (p21, p27) was graded semiquantitatively in a blinded
fashion in controls and at each time point in Thyl glomerulone-
phritis. Each rat was individually assessed. Thirty to fifty glomer-
ular cross sections from each biopsy were evaluated by counting
the number of nuclei that stained positive for each antigen
(positive was defined as a black staining nucleus), and the cell type
expressing each antigen was also scored (positive was defined as
the cobocalization of a brown cytoplasmic stain with a black
staining nucleus). Mean values per time point were calculated,
and are expressed as positive cells per 30 or 50 glomerular cross
section SEM.
Western blot analysis
Glomerular protein was extracted from individual animals by
isolating gbomeruli by differential sieving as previously described
[25]. In brief, the kidneys were decapsulated, and the cortex
separated from the medulla. The cortex was passed sequentially
through mesh sieves of 180, 106 and 75 m, and the purity of the
preparation was checked to ensure that there was less than 5%
tubular contamination with each glomerular preparation. Gb-
meruli were then resuspended in a buffer containing 1% triton,
10% Glycerol, 20 m 1-IEPES, 100 ms NaC1 with 10 rgJml
Leupeptin, 10 jrg/ml Antipain, 10 tg/ml Pepstatin, 0.1 mM sodium
orthovanadate and 50 mrvt sodium fluoride (reagents from Sigma).
Gbomeruli were sonicated for 20 seconds and then placed on ice
for 10 minutes, followed by centrifugation at 14000 rpm for five
minutes. The protein concentration of the supernatant was mea-
sured by the BCA protein assay (Pierce, Rockford, IL, USA)
according to the manufacturer's instructions.
For Western blot analysis, reducing buffer was added to 20 g
gbomerular protein extract, the amount loaded in each lane, and
boiled for five minutes. Gbomerular protein was then separated on
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Fig. 1. Quantitat ion of mesangial cell (MC) proliferation in the Thy] model
of experimental mesangial proliferative glomendonephritis. Cell proliferation
was determined by positive nuclear staining for proliferating cell nuclear
antigen (PCNA), and the MC was identified by cytoplasmic staining for
OX-7 (a marker specific for the MC). MC proliferation begins at day 2,
and was maximal at day 3. Resolution of MC proliferation was evident by
day 5, with complete resolution occurring by day 7. *p = 0.0031 vs. C;
**P < 0.0001 vs. C and other time points in Thyl; ***p = 0.0002 vs. C.
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Fig. 2. Quantitation of cyclin A +/OX-7+ staining. This figure shows the
number of cells that double-stained for cyclin A and OX-7 (a marker of
the mesangial cell) in thirty glomerular cross-sections from control rats
(labeled as C) and at different days of Thyl nephritis (days abbreviated as
d). Each time point represents the mean SEM of six animals. No staining
was detected in control rats, or at day 1 of Thyl. There was a significant
increase in the number of cells that stained cyclin A+/OX-7+ at day 2
(P < 0.0001 vs. control), with maximal staining occurring at day 3 (P <
0.0001 vs. control), which coincides with the peak of mesangial cell
proliferation. By day 4, cyclin A staining was absent. *p < 0.0001 vs. C, dl,
d4, d5; **p < 0.001 vs. d2.
Fig. 3. (Top panels) Indirect immunoperoxidase double-immunostaining fbr cyclin A (represented by the black nuclear stain), and OX-7, a marker of
mesangial cell (represented by the brown cytoplasmic stain). In the normal rat glomerulus, no staining was observed for cyclin A (A). B. Representative
staining in a glomerulus at day 3 of Thyl glomcrulonephritis that shows an increase in nuclei staining positive for cyclin A (examples are indicated by
the broad arrows). In the glomerulus shown, 2 nuclei stained positive for cyclin A. The majority of cyclin A positive nuclei colocalized with cells that
express OX-7, a marker of mesangial cells (represented by the thin arrows). Magnification ><63.
Fig. 6. (Middle panels) Indirect immunoperoxidase double-immunostainingjbr cyclin-dependent kinase 2 (CDK2) (represented by the black nuclear stain)
and OX-7, a marker of mesangial cell, ('represented by the brown cytoplasmic Stain). In the normal rat glomerulus shown, staining was observed for CDK2
in 2 nuclei (A). B. A representative glomerulus at day 3 of Thyl glomerulonephritis that shows an increase in nuclear staining positive for CDK2
(examples are indicated by the broad arrows). In this glomerulus 6 cells stained positive for CDK2. The majority of CDK2 positive nuclei colocalized
with cells that express OX-7 (represented by the thin arrows). Magnification X63.
Fig. 9. (Bottom panels) Indirect immunoperoxidase double-immunostaining for p21 (represented by the black nuclear stain) and OX-7, a marker of
mesangial cel4 (represented by the brown cytoplasmic stain). In the normal rat glomerulus shown, no staining was observed for p21 (A). B. A representative
glomerulus at day 5 of Thyl glomerulonephritis that shows an increase in nuclear staining for p21 (examples are indicated by the broad arrows),
colocalizing with OX-7 staining cells (examples are indicated by the thin arrows). Magnification X63.
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a 15% SDS-PAGE gel, and transferred to PVDF membranes
(Millipore, Bedford, MA, USA) by electroblotting. Complete
protein transfer was ensured by staining the gels with Coommasie
Blue. Non-specific background was blocked by incubating the
membranes with 5% non-fat dried milk for 30 minutes. Antibod-
ies to cyclin Dl, cyclin E, cyclin A, CDK2, p21 and p27'1 (source
for each antibody listed earlier) were incubated for one hour at
room temperature. An alkaline phosphatase-conj ugated second-
ary antibody (1:7500 dilution; Promega, Madison, WI, USA) was
applied for 60 minutes at room temperature, and protein detec-
tion was made with the chromagen, 5-Bromo-4-Chloro-3-Indolyl
phosphate/nitro blue tetrazolium (Sigma). Controls included
omitting the primary antibody, substituting the primary with
pre-immune serum, and peptide absorption of the primary anti-
body. To ensure that the results obtained by Western blot analysis
were not due to uneven protein loading or protein transfer, we
routinely stained the filters with Coommasie Blue.
Histone Hi assay
The activity of cyclin-dependent kinase 2 was determined in
individual rats by the histone Hi assay as previously described
[12]. Briefly, 500 xg of glomerular protein extract from individual
control rats, and rats at day 3 and day 5 of Thyi nephritis was
immunoprecipitated with antibodies to cyclin A or cyclin E for 30
minutes at 4°C. 50 .rl of Protein A sepharose beads (Repligen,
Cambridge, MA, USA) were then added to each immunoprecipi-
tation and incubated for 30 minutes at 4°C. This was followed by
the addition of histone Hi (Boehringer Mannheim, Indianapolis,
IN, USA), ATP (Pharmacia Biotech, Piscataway, NJ, USA) and
[32p] dCTP (Dupont, Boston, MA, USA) for a 60 minute incuba-
tion at 37°C. Negative controls included substituting pre-immune
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Fig. 4. Western blot analysis for cyclin A.
Twenty micrograms of glomerular protein from
control rats (lane 1) and rats at day 3 of Thyl
glomerulonephritis (lane 2) were loaded in each
lane, and was separated on a 15% SDS-PAGE.
— Cycho A No protein for cyclin A was detected in control
glomeruli. There was an increase in a 55 kDa
band at day 3 of Thyl glomeru!onephritis,
consistent with an increase in cyclin A protein.
The increase at day 3 of Thyl was not observed
when cyclin A was preincubated with
recombinant cyclin A protein (lane 3),
indicating the specificity of the antibody used.
Molecular weight markers in kDa are shown in
the left margin.
rabbit serum for cyclin E and cyclin A antibodies, and omitting the
primary antibody. Complexed recombinant cyclin E-CDK2 and
recombinant cyclin A-CDK2 were used as positive controls.
Reduced sample buffer was then added, and the mix was sepa-
rated on a 15% SDS-PAGE. The gel was exposed to autoradio-
graphic film (Amersham, Arlington, IL, USA).
Statistical analysis
At each time point, scores for immunohistochemical staining
was performed on individual animals, and expressed as mean
SEM unless stated otherwise. Statistical significance (defined as
P < 0.05) was evaluated by use of the Student's 1-test or one-way
analysis of variance with modified t-test performed with the
Bonferroni correction [29].
MC proliferation
We measured mesangial cell proliferation by double immuno-
staining with proliferating cell nuclear antigen (PCNA), a marker
for cell proliferation, and OX-7, a marker for mesangial cells.
Figure 1 shows that the normal rat glomerulus had a very low
mesangial cell proliferative rate, with less than I positive PCNA
cell per glomerulus, results similar to that observed by others [30].
Administration of the Thyl antibody causes early mesangiolysis at
day I (results not shown), which is associated with a reduction in
the number of mesangial cells, and a decrease in the number of
PCNA positive cells [20—22]. As shown in Figure 1, MC prolifer-
ation (PCNA+/OX-7+ cells) in Thy I glomerulonephritis begins
at day 2 (46.67 7.45 vs. 17.67 2.1 per 30 glomerular profiles;
P 0.0015 vs. control). By day 3 of Thyl, mesangial cell
proliferation (PCNA+IOX-7+ cells) was maximal, where the
increase was 5.21-fold compared to normal glomeruli (92.2 5.62
vs. 17.67 2.1 per 30 glomerular profiles; P < 0.0001 vs. control).
Mesangial cell proliferation started to resolve by day 5, and had
returned to baseline by day 7, which was maintained at day 10.
Cyclin A expression and not cyclins Dl or E, is increased during
mesangial cell proliferation in vivo
We performed double-immunostaining for cyclin A and specific
cell markers to identify which cell type expressed the cyclin A
antigen. Figure 2 shows quantitation for cells staining positive for
cyclin A and OX-7 (cyclin A+IOX-7+ cells), a marker of mesan-
gial cells. Cyclin A staining was absent in the normal rat glomer-
ulus. yclin A+/OX-7+ cell staining increased at day 2 of Thyl
Fig. 5. Quantitation of C'DK2+/OX-7+ staining. This Figure shows the
number of cells that double-stained for CDK2 and OX-7 (a marker of the
mesangial cell) in thirty glomerular cross-sections from control rats
(labeled as C) and at different days of Thyl nephritis (days labeled as d).
Each time point represents the mean SEM of six animals. There was an
increase in CDK2+/OX-7+ cells at day 2 of Thyl (P < 0.016 vs. C),
coinciding with the onset of mcsangial cell proliferation. Peak CDK2+/
OX-7+ staining was at day 3 (P < 0.0001 vs. C), at which time mesangial
cell proliferation was maximal. By day 4, baseline levels for CDK2+/
OX-7+ staining was observed, coinciding with the resolution of mesangial
cell proliferation. 'P < 0.0001 vs. C, dl, d4, d5; **p < 0.016 vs. d2.
glomerulonephritis (0 vs. 24 9.01; P < 0.0001 vs. control), which
coincided with the onset of mesangial cell proliferation. Staining
for cyclin A+/OX-7+ cells was maximal at day 3, where there was
a marked increase compared to controls (0 vs. 47 4.17; P <
0.0001). Figure 3 shows that staining for cyclin A was absent in the
normal control glomerulus. Figure 3 represents typical double
immunostaining for cyclin A and OX-7 at day 3 of Thyl glomer-
ulonephritis.
To determine if cyclin A was expressed by other cell types, we
performed double-immunostaining with ED-i (a marker of mac-
rophages and monocytes) and with RECA-1 (a marker of glomer-
ular endothelial cells). Eighty percent of the cells expressing cyclin
A were mesangial cells (cyclin A+IOX-7+). Of the 20% of
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Fig. 7. Cyclin dependent kinase 2 kinase activity.
Cyclin dependent kinase 2 (CDK2) activity was
measured by a histone Hi kinase assay. Each
lane represents 500 pg of glomerular protein
extracted from either control rats, or day 3 or
day 5 of Thyl glomerulonephritis that was
immunoprecipitated with an antibody to either
cyclin E or cyclin A. No kinase activity was
present in control glomeruli when
immunoprecipitated with antibodies to either
cyclin E (lane 1) or cyclin A (lane 4). When
CDK2 was immunoprecipitated with an
antibody to cyclin A at day 3 of Thyl (lane 5),
but not day 5 (lane 6), there was an increase in
a protein with a molecular weight of 33 kDA,
consistent with histone Hi, indicating that
CDK2 kinase activity was increased. No kinase
activity was detected at days 3 (lane 2) and 5
(lane 3) of Thyl when an antibody to cyclin E
was used for immunoprecipitation. Molecular
weight markers (in kDa) are shown in the left
margin.
glomerular cells that stained cyclin A+/OX-7—, 10% were mac-
rophages (cyclin A+/ED-i+), while the remaining 10% were
glomerular endothelial cells (cyclin A+/RECA-1+) at day 3. The
pattern of staining for cyclin A was similar if OX-7, ED-I and
RECA-1 were omitted.
To further confirm specificity for cyclin A staining in controls
and Thyl glomerulonephritis, we performed Western blot analysis
on protein lysates from isolated glomeruli, and the results are
shown in Figure 4. No cyclin A protein was present in control
glomeruli, but there was a protein of 55 kDa molecular weight at
day 3 of anti-Thyl glomerulonephritis, consistent with an increase
in glomerular cyclin A protein expression. When the primary
antibody to cyclin A was preincuhated with recombinant cyclin A,
no protein was detected (Fig. 4), indicating antibody specificity.
We also performed immunostaining and Western blot analysis
with antibodies to cyclin Dl and cyclin E in control rats and rats
with Thyl glomerulonephritis. No staining was present in paraffin
embedded or frozen fixed tissue, and no protein was detected by
Western blot analysis (results not shown). It is important to point
out that these antibodies recognize cyclin Dl and cyclin E in rat
mesangial cells in vitro by immunostaining and Western blot
analysis (personal observations).
Expression and activity Jbr CDK2 is increased in disease
We performed staining for CDK2 in control animals, and at
each time point in disease, and did double-labeling with cell
Fig. 8. Western blot analysis for p27'°''. Twenty
micrograms of glomerular protein was loaded in
each lane, and was separated on a 15% a SDS-
PAGE, and immunoblotted with an antibody to
p27Kvl. 27KP1 protein (represented here by a
protein with a molecular weight of 27 kDa) is
present in control glomeruli (lane 1) and day I
of Thyi glomerulonephritis (lanes 2), but was
reduced at day 3 (lane 3). p27KPl levels
were barely detectable at day 4 of Thyi
glomerulonephritis (lane 4). p27KPl expression
returned to baseline by day 5 (lane 5).
Molecular weight markers in kDa are shown in
the left margin.
specific markers to identify which cell types expressed this antigen.
Figure 5 shows quantitation for cells staining positive for CDK2
and OX-7 (CDK2+/OX-7+ cells), the latter which stains Thyl,
and is specific for mesangial cells. In the normal rat glomerulus
there was on average less than one CDK2+/OX-7+ cell per
glomerulus, results similar to the PCNA staining. Figure 5 shows
there was a substantial increase in CDK2+/OX-7+ cells (11.5
2.17 vs. 44.33 0.67 cells per 30 glomerular profiles) at day 2 of
Thyl (P < 0.0001), which coincided with the onset of MC
proliferation. The increase in CDK2+/OX-7+ cells was maximal
at day 3 (11.5 2.17 vs. 76.33 6.96; P < 0.0001), when
mesangial cell proliferation also peaked. The double-staining for
CDK2 and OX-7 is shown in Figure 6. By day 5 of Thyl,
CDK2+/OX-7+ staining was absent, at which time mesangial cell
proliferation was resolving.
Of the glomerular cells that stained for CDK2, 75% were
mesangial cells (CI)K2+/OX-7+ cell). Of the remaining cells that
expressed CDK2 (CDK2+/OX-7— cells), 15% were macrophages
(CDK2+/ED-1+), while the remainder were glomerular endothe-
hal cells (CDK2+/RECA-1+) (results not shown). The pattern
for CDK.2 staining was similar if OX-7, ED-I and RECA-1 were
omitted. Nuclear immunostaining was absent when the antibody
to cyclin-dependent kinase 2 was peptide absorbed, confirming
antibody specificity.
To determine if the activity for CDK2 was also increased during
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Fig. 10. Quantitation of p21+/OX-7+ staining. This figure shows the
number of cells that double-stained for p21 and OX-7 (a marker of the
mesangial cell) in fifty glomerular Cross-Sections from control rats (labeled
as C) and at different days of Thyl nephritis (days labeled as d). p21 is
absent in the normal rat glomerulus, and is increased at day 3 of Thy!, with
a peak at day 5, coinciding with the resolution of mesangial cell prolifer-
ation. p21 staining is present at days 7 and 10 of Thyl, when mesangial cell
proliferation is absent. p = 0.003 vs. C; * < 0.000 1 vs. C, P < 0.003 vs.
d3; **p = 0.001 vs. C, P = 0.01 vs. d3; ***p = 0.0008 vs. C, P = 0.01 vs.
d3.
mesangial cell proliferation in vivo, a histone Hi kinase assay was
performed on glomerular lysates. In the normal rat, no kinase
activity was observed when CDK2 was immunoprecipitated with
antibodies to cyclin E or cyclin A (Fig. 7). In contrast, MC
proliferation at day 3 of Thyl glomerulonephritis was associated
with a dramatic increase in CDK2 activity when immunoprecipi-
tated with an antibody to cyclin A (Fig. 7). The increase in kinase
activity coincided with the increase in expression for CDK2. No
kinase activity was present in Thyl glomerulonephritis when
CDK2 was immunoprecipitated with an antibody to cyclin E (Fig.
7), or when CDK2 was immunoprecipitated with pre-immune
serum to cyclin A and cyclin E antibodies (results not shown).
Mesangial cell proliferation is associated with a decrease in the
expression for 27KPl
Figure 8 shows a Western blot analysis on glomerular protein
lysates with an antibody to p27". p27' is expressed abun-
dantly in the normal quiescent glomerulus, and at day 1 and day
2 of Thyl glomerulonephritis. However, there was a decrease in
p27K levels at day 3, coincident with mesangial cell prolifera-
tion, and the levels were difficult to detect at day 4. By day 5 of
Thyl, p27° protein levels were at baseline, and this remained at
day 7. Specificity for the antibody to p27'<" was confirmed using
a p27'1 peptide. Coommasie Blue staining of all the filters used
in this study showed that protein loading was equal in the Western
blots used in the study (results not shown).
Nuclear staining for p27''' was observed in mesangial cells
(OX-7 positive), and also in glomerular endothelial (RECA-1
positive) and epithelial cells (results not shown). There was a
progressive reduction in glomerular immunostaining for p271
with the onset of Thyl glomerulonephritis, with the maximal
reduction in staining occurring at days 3 to 4 of disease, similar to
that observed by Western blot analysis. All three glomerular cell
types exhibited a similar pattern. There was a normalization of
p27'" staining by day 7, which coincided with the resolution of
mesangial cell proliferation (PCNA staining was at baseline
levels). Nuclear immunostaining was absent when the antibody to
p27'1 was peptide absorbed, confirming antibody specificity
(results not shown).
p21 expression increases, and is sustained in Thy]
glomerulonephritis
The protein expression for p21 was determined by immuno-
staining and Western blot analysis. We performed double immu-
nostaining to determine which cell type expressed p21. Figure 9
shows that staining for p21 is absent in the normal quiescent rat
glomerulus. Quantitation for cells staining positive for p21 and
OX-7 (p21+IOX-7+) during Thyi glomerulonephritis are shown
in Figure 10. p21+/OX-7+ staining was first observed at day 3 (0
vs. 20.5 4.3; P = 0.15 vs. control), and p21+IOX-7+ staining
was maximal at day 5 (93.33 11.05; P < 0.0001 vs. control). Of
particular interest was that p21+IOX-7+ staining was also
present at day 7 and day 10 of Thyl glomerulonephritis, at which
time no proliferation was detected. Double-immunostaining
showed that p21 only colocalized with OX-7 (Fig. 9), but not with
ED-i or RECA-1 (results not shown). p21 was therefore only
expressed by mesangial cells in this model. A common finding was
that p21 staining was localized at the vascular pole of the
glomerulus. Nuclear immunostaining was absent when the anti-
body to p21 was peptide absorbed, confirming antibody specificity.
The pattern for p21 staining was similar if OX-7, ED-i and
RECA-1 were omitted.
Figure 11 shows a Western blot analysis for p21 performed on
glomerular lysates in control rats, and rats with Thyl nephritis. In
the normal rat glomerulus, there is a very low basal expression for
p21. However, there is an increase in p21 protein levels at day 3
of disease, and the increase was progressive at days 5, 7 and was
still detected at day 10. Taken together, the increase in p21
expression coincides with the resolution of mesangial cell prolif-
eration in vivo.
Discussion
The role of cell-cycle proteins in proliferation has been well
documented in certain non-renal cells in vitro [8, 12]. However,
the expression of cell-cycle regulatory proteins has not been
described in the glomerulus, nor in renal disease in vivo. In the
current study we demonstrate that mesangial cell proliferation in
vivo in the Thyl model of experimental mesangial proliferative
glomerulonephritis is associated with an up-regulation of cyelin A,
and an increase in expression and activity for CDK2. We also
show that the normal glomerulus has high endogenous expression
of the CM, p27'1, and that the levels decrease with the initiation
of a MC proliferative response, while the resolution of MC
proliferation is associated with the normalization of p27 levels.
We also demonstrated that the CKI, p21, has low levels of
expression in the normal rat glomerulus, but that resolution of
mesangial cell proliferation is associated with an increase in p21
expression.
Quiescent cells in vitro do not express cyclins, but once stimu-
lated to enter the cell cycle by extracellular signals such as
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cytokines, cyclins are expressed and the levels oscillate throughout
the cell-cycle [31]. We initiated our study by examining the
expression of cyclins in normal rat glomeruli. Our first observation
in the current study was that the normal quiescent glomerulus in
vivo does not express the proteins for cyclins Dl, E or A, results
similar to in vitro studies in other cell lines [11, 31]. To study
mesangial cell proliferation in vivo and in disease, we selected the
Thyl model of mesangial proliferative glomerulonephritis, where
administration of the anti-Thy 1 antibody results in an acute phase
of complement-dependent mesangial cell lysis, followed by in-
tense mesangial cell proliferation [22—24] and mesangial matrix
accumulation [6]. Because the mesangial cell response to injury is
uniform in the Thy] model, most cells are typically synchronous in
their proliferative response to injury and general changes in cell
cycle proteins would be evaluated at the glomerular level. In
addition, by double immunostaining for the cell-cycle proteins
with mesangial cell, glomerular endothelial cell and macrophage
markers, it was possible to specifically determine changes in cell
cycle proteins in the individual cell populations.
In the current study, mesangial cell proliferation was associated
with a substantial up-regulation in expression for cyclin A. The
increase in cyclin A coincided with the onset of mesangial cell
proliferation in this model. We were unable to determine any
increase for cyclin Dl or E despite employing numerous different
staining methods. The antibodies to cyclins Dl and E used in this
study do recognize the rat antigens in mesangial cells in culture
(personal observation). However, we recognize that our inability
to detect these proteins may be due to low levels of expression for
these cell cycle proteins, their short half lives or because we did
not examine them at the time when they may have been increased.
In non-renal cells in vitro, the protein levels for cyclin depen-
dent kinases (CDKs) are typically constant throughout the cell
cycle, and are regulated post-translationaily [32]. CDKs are
activated by complexing to cyclins [33]. There is a very low cell
turnover in the normal rat glomerulus [30] In the normal rat
glomerulus, we observed that there were few cells that stained
positive for CDK2. However, our second observation in the
current study was that MC proliferation in Thyl glomeruloriephri-
tis was associated with a dramatic increase in the mesangial cell
expression for CDK2. The increase was first observed at day 2
which coincides with the onset of mesangial cell proliferation, and
was maximal at day 3, coinciding with peak PCNA staining. The
increase in CDK2 levels in this in vivo model differs therefore
from the in vitro observations where the levels for CDK2 usually
remain constant throughout the cell cycle. We have also observed
that the levels for CDK2 increase during rat mesangial cell
proliferation in vitro (unpublished observations). The increase in
Fig. 11. Western blot analysis for p2IC1.
Twenty micrograms of glomerular protein was
loaded in each lane, and was separated on a
15% a SDS-PAGE, and immunoblotted with an
antibody to p2lc, which is represented by a
protein of 21 kDa molecular weight (molecular
size markers are in the left margin). Protein
expression for p2l' was barely detectable in
control glomeruli (lane 1). There is an increase
in p2lCPI levels in Thyl glomerulonephritis,
first observed at day 3 (lane 2), which is
sustained at days 5 (lane 3), day 7 (lane 4), and
day 10 (lane 5) of Thyl glomerulonephritis.
cyclin A and CDK2 staining observed in the current study is not
due to a general increase in cell number, as there is only a twofold
increase in glomerular cell number in the Thyl model, while the
changes for the cell cycle proteins were greater than this. Al-
though PCNA staining peaked at day 3 of Thyl in the current
study, staining persisted at day 5, at which time no cyclin A or
CDK2 staining was observed. There are a few possible reasons to
explain why there is PCNA but not cyclin A!CDK2 staining at day
5. First, PCNA is a nuclear protein that is also expressed from late
GI phase to the M phase, whereas cyclin A and CDK2 are GuS
proteins [34], and second, PCNA has a half life exceeding that of
the GuS phase cell cycle proteins measured in this study [8, 34].
An increase in expression for CDK2 does not necessarily
correlate with kinase activity because activation of kinase activity
for each CDK is dependent on complexing with specific cyclins,
events that correlate with progression through the cell cycle [35].
Cyclin E and cyclin A associate with CDK2 [36], and cyclin
A-CDK2 complex is necessary for continued DNA replication
[13]. We next determined if the increased glomerular expression
of CDK2 was associated with an increase in kinase activity in vivo.
Kinase activity of CDK2 was absent in the normal glomerulus,
similar to that shown in quiescent cells in vitro. However, there
was a marked increase in glomerular kinase activity for CDK2 in
Thyl glomerulonephritis. Immunoprecipitation studies showed
that the increase was due to CDK2 complexing with cyclin A, and
not cyclin E. Because 25% of the cells that stained for CDK2 in
this study were not mesangial, it is possible that these cells may
have contributed to the kinase activity observed in Thyl nephritis.
A characteristic of many types of glomerular disease, including
Thyl glomerulonephritis, is the presence of proliferating macro-
phages in the glomerulus [37]. It was therefore not surprising that
cyclin A and CDK2 staining were observed in this cell type in the
current study. We have recently shown that there is early capillary
repair and angiogenesis in Thy] [38]. An increase in glomerular
endothelial cell expression for cyclin A and CDK2 in the current
study was also not surprising.
The cyclin kinase inhibitors (CM) p21 (also known as Cipi,
Wafi, Sdi) [18] and p27'1 [17] are negative regulators of the
cell-cycle, and play a critical role in regulating cell proliferation.
p21 and p27'' prevent cell cycle progression by inhibiting cyclin
D-CDK4, cyclin E-CDK2 and cyclin A-CDK2 complexes [15].
However, the expression of these CM may be cell type specific,
and their levels are also determined by their proliferative state
[40—42]. For example, resting macrophages [39] and fibroblasts
[40] contain high levels of p27'1 that decline when these cells are
stimulated to proliferate. In contrast, MvlLu lung epithelial and
human keratinocytes retain a high level of p27'" in their
1238 Shank/and et at: Cell cycle proteins during GN
proliferative state [41]. The expression for p21 is absent in
quiescent fibroblasts and levels increase during proliferation [40],
while p21 levels are high in resting HCA2 cells [42]. Furthermore,
a specific cytokine can alter the expression of cell cycle proteins
differently in different cell types. For example, TGF-f31 increases
the expression of p15 in keratinocytes [16], reduces the levels of
CDK4 in others [43], inhibits CDK2 complexes [44, 45] by
mobilizing p27 in MvlLu mink lung epithelial cells [17], and
increases the expression of p21 in the OVCA42O cell line [46].
Our third observation was that p27}I'l is endogenously ex-
pressed at high levels in the normal quiescent rat glomerulus, and
was present in mesangial cells, and in glomerular endothelial and
epithelial cells. Mesangial cell proliferation in Thyl glomerulone-
phritis was associated with a decrease in p27 expression, which
was marked at day 3 and day 4 of Thy 1, when MC proliferation
was maximal. Resolution of mesangial cell proliferation was
associated with the return to baseline expression for p27""
(pZ7). One may speculate that the p27KPI expression may help
explain in part the low cell turnover that has been observed in the
normal rat glomerulus [30]. Although most of the glomerular cell
proliferation in this model represents the mesangial cell, there is
also proliferation of glomerular endothelial cells that occurs [38].
The decrease in glomerular p27 levels would be consistent with a
role for stimulating mesangial and endothelial cell proliferation in
this model.
Our fourth finding was that there is a differential expression for
the CKIs, p21 and p27, in control and disease. In the normal
quiescent rat glomerulus we could not detect staining for p21,
which contrasted with the high endogenous expression for p27.
While the levels for p27 were decreased during mesangial cell
proliferation in vivo, there was a marked increase in p21 protein
expression by the mesangial cells. Unlike other cell cycle proteins
in this study, p21 was only expressed by the mesangial cell during
Thyl glomerulonephritis. The peak in p21 staining coincided with
the resolution of mesangial cell proliferation in vivo. Furthermore,
at day 7 and day 10 of Thyl where MC proliferation was absent,
p21 was still expressed by mesangial cells. The significance of p21
commonly localizing to the vascular pole of the glomerulus is not
known. This differs from that described in vitro studies in non-
renal cells, where p21 levels increase during proliferation, hut are
absent during quiescence [40]. The reason for the sustained
increase is unknown. p21 prevents cell proliferation in two ways.
First the N terminus of p21 binds to and inhibits cyclin-CDK
complexes [47], and second the C-terminus inhibits proliferating
cell nuclear antigen (PCNA) [48], an auxiliary protein to DNA
polymerase. A role for p21 in vivo was recently shown where the
overexpression of p21 prevented vascular smooth muscle cell
proliferation in a carotid model of balloon angioplasty [49]. Our
results suggest that p21 may be important for the resolution of
MC proliferation in the Thyl model.
The differential expression for the CKI in the Thyl model
emphasizes that not all CKI behave similarly, and that specific
CKI may have function in individual cell types or initiating or
resolving cell proliferation. This has been suggested in previous
studies in which mutations in certain CKI (for example, p16)
predispose to cancers in certain cell lineages (for example mela-
noma), as opposed to a general increase in cancers in all cell types
[50]. Furthermore, the studies reported herein again emphasize
that in vivo observations do not always reproduce what is observed
in vitro. Thus, the demonstration that in vivo mesangial cell
proliferation is associated with increased expression of CDK2 has
not been observed in non-renal cells in vitro [10]. Second, the
sustained increase in p21 in mesangial cells in vivo even after
proliferation has subsided differs from the transient expression of
p21 that occurs during non-renal cell proliferation in vitro [40].
In the current study we did not determine the mechanisms
responsible for the changes in cell-cycle regulatory protein expres-
sion that accompanies mesangial cell proliferation in vivo. In vitro
studies have shown that positive and negative regulatory cell-cycle
proteins are regulated by various cytokines. Mesangial cell prolif-
eration in the Thyl model is induced by PDGF and bFGF [51].
TGF-/31 is also increased in this model [52], but the role of this
cytokine in regulating MC proliferation during Thyl nephritis is
unknown. The changes observed in cell-cycle protein expression in
the current study may be due to these and other cytokines. In
conclusion, we have shown that certain cell-cycle regulatory
proteins are expressed during mesangial cell proliferation in vivo.
Further studies are needed to determine their functional role.
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